Gaithersburg, MD’s Altimmune has secured a sizable contract with BARDA to further develop its nasal spray anthrax vaccine candidate, building on an existing collaboration as the biotech prepares to move into clinical trials.
{iframe}http://www.fiercepharma.com/vaccines/altimmune-wins-120m-barda-contract-to-advance-nasal-spray-anthrax-vaccine{/iframe}